Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
about
Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic miceThe use of transcriptomics to unveil the role of nutrients in Mammalian liver.A novel dual-color reporter for identifying insulin-producing beta-cells and classifying heterogeneity of insulinoma cell linesAn 8-wk, randomized, double-blind, placebo-controlled clinical trial for the antidiabetic effects of hydrolyzed ginseng extract.Study of the Effect of Panax Ginseng versus Gliclazide on Hyperglycaemia Induced by Dexamethasone in Experimental AnimalsBioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosidesSystems biology of meridians, acupoints, and chinese herbs in disease.Effects of Cyclo-His-Pro-enriched yeast hydrolysate on blood glucose levels and lipid metabolism in obese diabetic ob/ob mice.Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application.Enhanced Absorption Study of Ginsenoside Compound K (20-O-β-(D-Glucopyranosyl)-20(S)-protopanaxadiol) after Oral Administration of Fermented Red Ginseng Extract (HYFRG™) in Healthy Korean Volunteers and Rats.EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET β CELL IN VITRO.Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach.Enhanced antidiabetic efficacy and safety of compound K⁄β-cyclodextrin inclusion complex in zebrafish.Intestinal bacterial transformation - a nonnegligible part of Chinese medicine research.Ginseng and diabetes: the evidences from in vitro, animal and human studies.Clinical implication of SGLT2 inhibitors in type 2 diabetes.20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.Synthesis of esters of ginsenoside metabolite M1 and their cytotoxicity on MGC80-3 cells.Anti-Diabetic Effect of Pectinase-Processed Ginseng Radix (GINST) in High Fat Diet-Fed ICR Mice.Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng.Determination of ginsenoside compound K in human plasma by liquid chromatography-tandem mass spectrometry of lithium adductsPectinase-Processed Ginseng Radix (GINST) Ameliorates Hyperglycemia and Hyperlipidemia in High Fat Diet-Fed ICR MiceHypoglycaemic effects of functional tri-peptides from silk in differentiated adipocytes and streptozotocin-induced diabetic mice.Anti-hyperglycemic effect of fermented ginseng in type 2 diabetes mellitus mouse model.Lipid metabolic effect of Korean red ginseng extract in mice fed on a high-fat diet.Effects of Panax ginseng supplementation on muscle damage and inflammation after uphill treadmill running in humans.Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats.The impact of Rhodiola rosea on the gut microbial community of Drosophila melanogaster.
P2860
Q33358112-124185AA-6FD3-4754-875C-581B3E3AE40EQ33710347-D70020E8-9DC2-4575-8EE2-EEEE1DEF8540Q34243843-61655608-17DB-40C4-982D-049B46546F20Q34424578-0882DA33-3884-45C2-8BA5-6D28981F06F3Q34782632-0503D46C-A502-4D6D-8EE6-58457E805268Q35950044-7E61C576-C039-4D93-8042-6ED935657722Q36355849-B2FF133D-6D63-4F55-8234-5C376944A6A0Q36760463-FFF30E68-0C90-4E73-B0CB-22C372E93B3DQ36861245-04D1D4F8-E5CE-409E-91FB-D98F0DC4C74BQ37144349-441AFC33-13A5-4E7F-A98B-2064FD49FBCEQ37191153-41F4AB2A-4793-4A28-9722-424729FAA938Q37399585-1325C205-1B5F-4D44-B95D-ACB6430660C2Q37575726-8B5F5D06-A50F-48D0-9F33-722D8BDC8389Q38101342-7C36224E-F523-4A62-963C-13593B2E401BQ38110276-68FCC0E8-E69F-4112-A5CA-17430BEED6C2Q38221980-A322A717-24C6-44C9-9D70-093D0E44A64FQ38995606-285C51E3-9131-4C1C-92CD-F37E691CFA9AQ39101221-0DBF0DED-0AC9-4935-8FA6-337985132C75Q39175723-B33B0E74-1EDB-4A7B-9159-C72FF239C549Q40877016-27E6A956-FDCE-4032-AE28-CD26ECBAFF65Q40877695-8715D729-111D-4F4F-94B5-E97C28FE24FAQ41952897-256ED7F6-8F05-4275-B144-74EEDADE3F73Q42040754-DC9B9881-6ED4-4D01-90FF-DD234C2003D2Q42470999-D2360D93-59D7-44BA-AC10-F377B080F46FQ45138032-EBD1FC0B-F5AF-4569-8809-AC45EF5A58EFQ50526203-262FD3A9-CA3A-4246-B762-74461781CF61Q50535872-D037DEAC-6EFF-409B-9A86-E43C250DF915Q51159954-210DD394-7E43-47F9-ADAC-43532263F399Q51759212-A1E39A74-6378-4024-999D-248172208633
P2860
Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
@en
type
label
Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
@en
prefLabel
Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
@en
P2093
P356
P1476
Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
@en
P2093
Gi Cheol Han
Jong Hwan Sung
Sung Hyun Chung
Sung Kwon Ko
P304
10641-10648
P356
10.1021/JF0722598
P407
P577
2007-11-23T00:00:00Z